Impact of a recent cancer diagnosis on bleeding risk after myocardial infarction
In this real-world observational study, patients with cancer had an increased bleeding risk in the first year post-MI which decreased but persisted in the second year after MI. Bleeding risk in patients with cancer must be carefully assessed post-MI.
Authors
- Paul C. Lambert (ORCID: https://orcid.org/0000-0002-5337-663X)
- Sally Vernon (ORCID: https://orcid.org/0009-0007-6290-715X)
- Mark J. Rutherford (ORCID: https://orcid.org/0000-0003-1557-6697)
- Clive Weston (ORCID: https://orcid.org/0000-0002-8995-8199)
- Florian A. Wenzl (ORCID: https://orcid.org/0000-0001-6654-9918)
- Kok Weng Ow (ORCID: https://orcid.org/0000-0002-2729-6863)
- Lizz Paley (ORCID: https://orcid.org/0000-0002-3879-5377)
- Mark de Belder (ORCID: https://orcid.org/0000-0003-2690-8319)
- Jennifer Lai (ORCID: https://orcid.org/0000-0002-0593-1424)
- Freek Van den Berg
- Michael Peake
- John Deanfield
- Freya Tyrer
- David Adlam
Institutions
- Norwegian Institute of Public Health (NO)
- University Medical Center Groningen (NL)
- University of Leicester (GB)
- Queen Mary University of London (GB)
- University of Zurich (CH)
- Glangwili General Hospital (GB)
- Karolinska Institutet (SE)
- British Heart Foundation (GB)
- Observational & Pragmatic Research Institute (SG)
- Cancer Registry of Norway (NO)
- Health Economics and Outcomes Research (United Kingdom) (GB)
- William Harvey Research Institute (GB)
- National Cancer Registration Service (GB)
- NIHR Research Delivery Network (GB)
- NIHR Leicester Biomedical Research Centre (GB)
- NHS England
- University College London (GB)
Publication Details
- Journal
- Heart
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1136/heartjnl-2025-326524
- Citations
- 1
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Amgen
- Pfizer
- AstraZeneca
- Sanofi
- Foundation for Cardiovascular Research
- Cancer Research UK
- National Institute for Health and Care Research
- British Heart Foundation
- Department of Health and Social Care
- European Society of Cardiology
- Novo Nordisk
- Schweizerische Herzstiftung
- Universität Zürich
- Karl-Franzens-Universität Graz
- Medizinische Universität Graz
- Sphingotec GmbH
- Abbott Vascular
- Medical Research Council